Avery Therapeutics, Inc.: Funding, Investors & Team (Sep 2026)
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat diseases and injuries to human muscle.
Avery Therapeutics, Inc. has raised $8.5M across 1 funding round on record, the most recent an undisclosed round of $8.5M announced in Sep 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avery Therapeutics, Inc. Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Avery Therapeutics, Inc. Funding Rounds
Avery Therapeutics, Inc. Founders and Leadership Team
Contact details for the Avery Therapeutics, Inc. team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Avery Therapeutics, Inc. Funding Compared to Other Biotechnology Startups
Avery Therapeutics, Inc.'s latest round of $8.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avery Therapeutics, Inc. in Biotechnology and Tucson
Companies Similar to Avery Therapeutics, Inc.
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Avery Therapeutics, Inc. Funding FAQs
What does Avery Therapeutics, Inc. do?
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat diseases and injuries to human muscle.
How much funding has Avery Therapeutics, Inc. raised?
Avery Therapeutics, Inc. has raised $8.5M across 1 round on record. The most recent is an undisclosed round of $8.5M announced in Sep 2026.
When did Avery Therapeutics, Inc. last raise funding?
Avery Therapeutics, Inc.'s most recent funding round on record is an undisclosed round of $8.5M, announced in Sep 2026.
Who is the CEO of Avery Therapeutics, Inc.?
Jordan Lancaster is listed as Chief Executive Officer at Avery Therapeutics, Inc..
Where is Avery Therapeutics, Inc. headquartered?
Avery Therapeutics, Inc. is based in Tucson, United States.
How many employees does Avery Therapeutics, Inc. have?
Avery Therapeutics, Inc. is in the 1-10 employee band.
When was Avery Therapeutics, Inc. founded?
Avery Therapeutics, Inc. was founded in 2014.
How does Avery Therapeutics, Inc.'s funding compare to other Biotechnology startups?
Avery Therapeutics, Inc.'s latest round of $8.5M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Avery Therapeutics, Inc. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avery Therapeutics, Inc. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.